Corrigendum to "Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed" [Eur J Cancer 202, May 2024, 114006].

Leonetti A, Perrone F, Puntoni M, Maglietta G, Bordi P, Bria E, Vita E, Gelsomino F, De Giglio A, Gelibter A, Siringo M, Mazzoni F, Caliman E, Genova C, Bertolini F, Guaitoli G, Passiglia F, Delcuratolo MD, Montrone M, Cerea G, Pasello G, Roca E, Belluomini L, Cecere FL, Guida A, Manzo A, Adamo V, Rastelli F, Bulotta A, Citarella F, Toschi L, Zoratto F, Cortinovis DL, Berardi R, Follador A, Carta A, Camerini A, Salerno F, Silva R, Baldini E, Cortellini A, Brighenti M, Santoni M, Malorgio F, Caminiti C, Tiseo M.

Open source

DOI
10.1016/j.ejca.2026.116901
Published
2026-06-27
Container
Eur J Cancer
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ejca.2026.116901,
  title = {Corrigendum to "Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed" [Eur J Cancer 202, May 2024, 114006].},
  author = {Leonetti A and  Perrone F and  Puntoni M and  Maglietta G and  Bordi P and  Bria E and  Vita E and  Gelsomino F and  De Giglio A and  Gelibter A and  Siringo M and  Mazzoni F and  Caliman E and  Genova C and  Bertolini F and  Guaitoli G and  Passiglia F and  Delcuratolo MD and  Montrone M and  Cerea G and  Pasello G and  Roca E and  Belluomini L and  Cecere FL and  Guida A and  Manzo A and  Adamo V and  Rastelli F and  Bulotta A and  Citarella F and  Toschi L and  Zoratto F and  Cortinovis DL and  Berardi R and  Follador A and  Carta A and  Camerini A and  Salerno F and  Silva R and  Baldini E and  Cortellini A and  Brighenti M and  Santoni M and  Malorgio F and  Caminiti C and  Tiseo M.},
  year = {2026},
  journal = {Eur J Cancer},
  doi = {10.1016/j.ejca.2026.116901},
  url = {https://doi.org/10.1016/j.ejca.2026.116901}
}

RIS

TY  - JOUR
TI  - Corrigendum to "Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed" [Eur J Cancer 202, May 2024, 114006].
AU  - Leonetti A
AU  -  Perrone F
AU  -  Puntoni M
AU  -  Maglietta G
AU  -  Bordi P
AU  -  Bria E
AU  -  Vita E
AU  -  Gelsomino F
AU  -  De Giglio A
AU  -  Gelibter A
AU  -  Siringo M
AU  -  Mazzoni F
AU  -  Caliman E
AU  -  Genova C
AU  -  Bertolini F
AU  -  Guaitoli G
AU  -  Passiglia F
AU  -  Delcuratolo MD
AU  -  Montrone M
AU  -  Cerea G
AU  -  Pasello G
AU  -  Roca E
AU  -  Belluomini L
AU  -  Cecere FL
AU  -  Guida A
AU  -  Manzo A
AU  -  Adamo V
AU  -  Rastelli F
AU  -  Bulotta A
AU  -  Citarella F
AU  -  Toschi L
AU  -  Zoratto F
AU  -  Cortinovis DL
AU  -  Berardi R
AU  -  Follador A
AU  -  Carta A
AU  -  Camerini A
AU  -  Salerno F
AU  -  Silva R
AU  -  Baldini E
AU  -  Cortellini A
AU  -  Brighenti M
AU  -  Santoni M
AU  -  Malorgio F
AU  -  Caminiti C
AU  -  Tiseo M.
PY  - 2026
JO  - Eur J Cancer
DO  - 10.1016/j.ejca.2026.116901
UR  - https://doi.org/10.1016/j.ejca.2026.116901
ER  -

APA

A, L., F, P., M, P., G, M., P, B., E, B., E, V., F, G., A, D. G., A, G., M, S., F, M., E, C., C, G., F, B., G, G., F, P., MD, D., M, M., G, C., G, P., E, R., L, B., FL, C., A, G., A, M., V, A., F, R., A, B., F, C., L, T., F, Z., DL, C., R, B., A, F., A, C., A, C., F, S., R, S., E, B., A, C., M, B., M, S., F, M., C, C., & M., T. (2026). Corrigendum to "Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed" [Eur J Cancer 202, May 2024, 114006].. Eur J Cancer. https://doi.org/10.1016/j.ejca.2026.116901

Source records